Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating or reducing the risk of cardiovascular events and related diseases using SGLT-2 inhibitors

Methods of treating or reducing the risk of cardiovascular events and related diseases using SGLT-2 inhibitors

US Patent 12036203 · Granted Jul 16, 2024

Estimated economic value: $357,475,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

AMPK activators2023
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2020
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2020
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2019
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2019
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2019
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2019
Methods for treating cardiovascular disease using a soluble CTLA4 molecule2010
Methods for treating immune disorders associated with graft transplantation with2009
Methods for treating cardiovascular disease using a soluble CTLA4 molecule2007